Earnings Preview: Fulgent Genetics
Portfolio Pulse from Benzinga Insights
Fulgent Genetics (NASDAQ:FLGT) is set to release its latest quarterly earnings report on November 3, 2023. Analysts estimate an earnings per share (EPS) of $-0.33. The company's stock performance has been generally negative over the last 52-week period, with shares down 38.56%. The company's guidance for the next quarter will be crucial for the stock's performance.
November 02, 2023 | 5:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Fulgent Genetics is expected to report an EPS of $-0.33 in its upcoming earnings report. The company's stock has been performing negatively, with a 38.56% decrease over the last 52 weeks. The company's guidance for the next quarter will be a key factor influencing the stock's performance.
The company's stock has been performing negatively over the past year, which indicates a bearish sentiment among investors. The upcoming earnings report, particularly the company's guidance for the next quarter, will likely have a significant impact on the stock's performance. If the company fails to meet the EPS estimate or provides a negative guidance, the stock price could further decrease.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100